Mates Sharon
The estimated Net Worth of Mates Sharon is at least $39 Million dollars dollars as of 01/26/2021. Mates Sharon is the Chairman, President & CEO of Intra-Cellular Therapies Inc. Mates Sharon owns over 1,133,392 shares of Intra-Cellular Therapies Inc stock worth over $39 Million dollars .
Mates Sharon
mailing address: C/O INTRA-CELLULAR THERAPIES, INC. 3960 BROADWAY NEW YORK NY 10032
Insider Roles
| Name | Transaction Date | Position |
|---|---|---|
| Intra-Cellular Therapies Inc | 2020-02-18 | director, officer: Chairman, President & CEO |
Mates Sharon trading transactions
| Ticker | Company | Price | Insider Name | Insider Position | Date | Buy/Sell | Insider Trading Shares | Shares Change | Price | Cost(000) | Final Share | Price Change Since Insider Trade (%) | Dividend Yield % | PE Ratio | Market Cap ($M) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company | Price | Insider Name | Insider Position | Date | Buy/Sell | Insider Trading Shares | Shares Change | Price | Cost(000) | Final Share | Price Change Since Insider Trade (%) | Dividend Yield % | PE Ratio | Market Cap ($M) | ||
| ITCI | Intra-Cellular Therapies Inc | $34.01 | Mates Sharon | Chairman, President & CEO | 2021-01-11 | Sell | 41,896 | -3.56% | $32.01 | $1,341.09 | 1,133,392 | 6.25% | 0 | 0 | 2,726.16 | ||
| ITCI | Intra-Cellular Therapies Inc | $34.01 | Mates Sharon | Chairman, President & CEO | 2021-01-04 | Sell | 48,341 | -4.09% | $31.30 | $1,513.07 | 1,133,392 | 8.66% | 0 | 0 | 2,726.16 | ||
| ITCI | Intra-Cellular Therapies Inc | $34.01 | Mates Sharon | Chairman, President & CEO | 2020-11-10 | Sell | 50,000 | -4.30% | $26.34 | $1,317 | 1,113,392 | 29.12% | 0 | 0 | 2,726.16 | ||
| ITCI | Intra-Cellular Therapies Inc | $34.01 | Mates Sharon | Chairman, President & CEO | 2020-11-04 | Sell | 50,000 | -4.12% | $25 | $1,250 | 1,163,392 | 36.04% | 0 | 0 | 2,726.16 | ||
| ITCI | Intra-Cellular Therapies Inc | $34.01 | Mates Sharon | Chairman, President & CEO | 2020-01-09 | Sell | 41,895 | -3.36% | $26.16 | $1,095.97 | 1,204,707 | 30.01% | 0 | 0 | 2,726.16 | ||
| ITCI | Intra-Cellular Therapies Inc | $34.01 | Mates Sharon | Chairman, President & CEO | 2020-01-06 | Sell | 45,598 | -3.53% | $30.28 | $1,380.71 | 1,246,602 | 12.32% | 0 | 0 | 2,726.16 | ||
| ITCI | Intra-Cellular Therapies Inc | $34.01 | Mates Sharon | Chairman, President & CEO | 2020-01-02 | Sell | 17,478 | -1.45% | $32.45 | $567.16 | 1,190,305 | 4.81% | 0 | 0 | 2,726.16 | ||
| ITCI | Intra-Cellular Therapies Inc | $34.01 | Mates Sharon | Chairman, President & CEO | 2019-01-07 | Sell | 52,202 | -4.38% | $11.58 | $604.50 | 1,138,707 | 193.70% | 0 | 0 | 2,726.16 | ||
| ITCI | Intra-Cellular Therapies Inc | $34.01 | Mates Sharon | Chairman, President & CEO | 2019-01-02 | Sell | 17,478 | -1.45% | $11.09 | $193.83 | 1,184,305 | 206.67% | 0 | 0 | 2,726.16 | ||
| ITCI | Intra-Cellular Therapies Inc | $34.01 | Mates Sharon | Chairman, President & CEO | 2018-01-08 | Sell | 6,604 | -0.60% | $17.48 | $115.44 | 1,088,707 | 94.57% | 0 | 0 | 2,726.16 | ||
| ITCI | Intra-Cellular Therapies Inc | $34.01 | Mates Sharon | Chairman, President & CEO | 2018-01-05 | Sell | 11,257 | -1.02% | $17.08 | $192.27 | 1,095,311 | 99.12% | 0 | 0 | 2,726.16 | ||
| ITCI | Intra-Cellular Therapies Inc | $34.01 | Mates Sharon | Chairman, President & CEO | 2017-10-30 | Sell | 18,750 | -1.69% | $15.75 | $295.31 | 1,088,707 | 115.94% | 0 | 0 | 2,726.16 | ||
| ITCI | Intra-Cellular Therapies Inc | $34.01 | Mates Sharon | Chairman, President & CEO | 2017-01-05 | Sell | 4,081 | -0.37% | $16.55 | $67.54 | 1,088,707 | 105.50% | 0 | 0 | 2,726.16 | ||
| ITCI | Intra-Cellular Therapies Inc | $34.01 | Mates Sharon | Chairman, President & CEO | 2015-12-11 | Sell | 51,500 | -4.53% | $53.87 | $2,774.30 | 1,086,185 | -36.87% | 0 | 0 | 2,726.16 | ||
| ITCI | Intra-Cellular Therapies Inc | $34.01 | Mates Sharon | Chairman, President & CEO | 2014-11-28 | Sell | 35,000 | -3.17% | $14.75 | $516.25 | 1,068,935 | 130.58% | 0 | 0 | 2,726.16 |
Total 15
- 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.
Mates Sharon personal network
| Name | Position | Linked company |
|---|